摘要
In this study, a type of small extracellular vesicles (sEVs) modified with two immunosuppressive molecules was successfully constructed (PDL1-Siglec15-sEVs). Using 3D bioprinting technology, these sEVs were loaded into a multifunctional hydrogel, allowing for continuous and on-demand release of PDL1-Siglec15-sEVs under physiological conditions. This approach was aimed at enhancing and prolonging the therapeutic effect of PD-1/PD-L1 immune checkpoint blockade. • In vitro, the hydrogel system significantly suppressed immune cell activation and attenuated pro-inflammatory responses in keratinocytes. In vivo, it markedly accelerated wound closure, enhanced keratinocyte and fibroblast proliferation and migration, facilitated robust re-epithelialization, and promoted organized deposition of key extracellular matrix components—including collagen I, fibronectin, and hyaluronic acid. • Mechanistically, the therapeutic effect is mediated through a coordinated multimodal action: (i) upregulation of keratin KRT32 in keratinocytes, which stabilizes epidermal integrity; (ii) suppression of NF-κB signaling, thereby dampening chronic inflammation; (iii) potentiation of PD-1/PD-L1–mediated immunosuppression at the wound site; and (iv) induction of M2 macrophage polarization, fostering a pro-regenerative immune microenvironment. Excessive or persistent inflammation intensifies skin tissue damage, leading to abnormal repair processes like scar hyperplasia, and potentially causing chronic wound non-healing or even malignant transformation. The effective enhancement of wound repair and regeneration is impeded by the challenge of precisely suppressing overactivated immune cells, repairing damaged skin cells, and rapidly reconstructing a stable local immune microenvironment. We engineered small extracellular vesicles (sEVs) co-overexpressing PDL1 and Siglec15 (PDL1-Siglec15-sEVs), these PDL1-Siglec15-sEVs were encapsulated within photocurable hydrogels to create a multifunctional hydrogel-based therapeutic system (PDL1-Siglec15-sEVs@NHT). This system continuously releases PDL1-Siglec15-sEVs into the surrounding microenvironment at physiological temperature. In vitro experiments demonstrated that PDL1-Siglec15-sEVs exert an immune reprogramming effect, significantly inhibiting PBMC proliferation and reducing the proportion of CD8 + T cells. Furthermore, they effectively suppressed ROS generation in HaCaT cells and diminished the expression of multiple inflammatory factors. This multifunctional hydrogel composite system accelerated wound closure and promoted re-epithelialization in a rat full-thickness skin defect model by stimulating skin cell proliferation, migration, and extracellular matrix deposition. Transcriptome sequencing revealed that PDL1-Siglec15-sEVs profoundly upregulated Krt32 expression in skin keratinocytes while inhibiting activation of the NF-κB mediated inflammatory signaling pathway. PDL1-Siglec15-sEVs significantly promote skin wound healing through multifaceted mechanisms, synergistically enhancing the immunosuppressive effect mediated by the PD1/PDL1 pathway, reducing keratinocyte inflammatory responses, and fostering the polarization of M2-type macrophages.
危险品化学品经营许可证(带存储)